ArticleJournal of pain research2026
Effect of Vibration Anesthesia on Injection-Related Pain: A Prospective Crossover Study.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Vibration Anesthesia on Injection-Related Pain: A Prospective Crossover Study [Letter].Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Needle-based procedures, including intramuscular (IM) and subcutaneous (SC) injections and fingersticks, are essential to healthcare but frequently associated with pain and anxiety. Vibration anesthesia leverages the gate control theory by stimulating competing sensory pathways to reduce nociceptive transmission. DigiVibe (Suthe Dermal) is a handheld, FDA-registered vibration device designed to mitigate needle-related pain. This study evaluated DigiVibe's (Suthe Dermal) effect on pain during common needle procedures. Methods: Twenty (20) healthy adults (50% female; mean age 37.5 years) reporting needle aversion underwent six procedures in a single visit including fingersticks, SC injections, and IM injections, each performed once without intervention (control) and once with DigiVibe (Suthe Dermal) applied before and during needle insertion. Pain was assessed immediately after each procedure using a 10-point Visual Analog Scale (VAS). Primary endpoints included mean paired VAS differences analyzed via Paired Results: DigiVibe (Suthe Dermal) significantly reduced pain across all procedure types. Mean VAS reductions were -2.65 for SC injections (p<0.001; d= -1.66), -2.00 for IM injections (p<0.001; d= -1.23), and -1.75 for fingersticks (p<0.001; d= -1.13). Nonparametric results confirmed large effect sizes (rank-biserial r = -1.0, -0.96, and -0.88, respectively). Sixty-five percent (65%) of subjects experienced no pain with DigiVibe (Suthe Dermal) during fingersticks and 95% achieved ≥30% pain reduction for SC injections. No adverse events occurred. Conclusion: DigiVibe (Suthe Dermal) produced statistically significant and clinically meaningful reductions in pain across IM, SC, and fingerstick procedures in adults with needle aversion. These findings support vibration anesthesia as a safe, non-pharmacologic method to enhance comfort and potentially improve adherence to needle-based care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.